United States· US:50090-5886_1667fb24-4776-43db-b29b-3cfa228d82d0
Buspirone Hydrochloride
A buspirone product containing buspirone hydrochloride, registered in United States by A-S Medication Solutions. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Buspirone is registered in 12 of 19 countries.
Countries holding a registration under ATC N05BE01 (buspirone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Buspirone · ATC N05BE01
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of buspirone costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buspirone · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- FR France$0.60
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- A-S Medication Solutions
- Country
- United States (US)
- ATC code
- N05BE01
- ATC class
- Buspirone
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1150090-5886-0
- ndc1150090-5886-1
- ndc1150090-5886-3
- ndc115009058860500 TABLET in 1 BOTTLE (50090-5886-0)
- ndc11500905886160 TABLET in 1 BOTTLE (50090-5886-1)
- ndc11500905886390 TABLET in 1 BOTTLE (50090-5886-3)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for buspirone.
Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buspirone · interactions on record
258 records
- 22 severe
- 118 moderate
- 118 info
Most severe, free to view
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- PalonosetronA04AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buspirone in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBuspirone 15mg tabletsA A H Pharmaceuticals Ltd
- SwedenAnksilon 10 mg TablettOrion Corporation
- FinlandAnksilonOrion Corporation Orion Pharma
- CanadaAMB-BUSPIRONEAMBICARE PHARMACEUTICALS INC.
- PolandSpamilanDelfarma Sp. z o.o.
- NorwayBuripal2care4 Generics ApS
- CzechiaBUSPIRON-EGISEgis Pharmaceuticals PLC, Budapešť
- NetherlandsBuspiron HCl CF 10 mg, tablettenCentrafarm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Czechia · Buspiron-Egis
- Germany · Busp
- Denmark · Buripal, Buspiron Actavis
- Finland · Anksilon, Buspiron Ratiopharm
- France · Buspirone Sandoz, Buspirone Viatris
- United Kingdom (Northern Ireland) · Buspirone Accord-Uk, Buspirone Hydrochloride
- Greece · Antipsichos, Bergamol
- Hungary · Spitomin
- Lithuania · Spitomin
- Latvia · Spitomin
- Netherlands · Buspiron Hcl Cf, Buspiron Hcl Mylan
- Norway · Buripal, Buspirone Orion
- Poland · Spamilan
- Portugal · Ansiten, Busansil
- Romania · Spitomin
- Sweden · Anksilon, Buripal
- Slovakia · Spitomin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d80c28ba-e200-4c32-b349-efa5d506012a GET /v1/drugs/d80c28ba-e200-4c32-b349-efa5d506012a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "15",
"substance": "BUSPIRONE HYDROCHLORIDE",
"productndc": "50090-5886",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA075022",
"marketing_category": "ANDA"
}See everything about buspirone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.